Researcher from University of Cambridge Details Findings in Antineoplastics (Bexarotene leads to durable improvements in visual evoked potential latency: A follow-up study of the Cambridge Centre for Myelin Repair One trial)

Source :: Obesity, Fitness & Wellness Week. March 23, 2024, 4757
Publication Year :: 2024
Abstract: 2024 MAR 23 (NewsRx) -- By a News Reporter-Staff News Editor at Obesity, Fitness & Wellness Week -- Investigators publish new report on antineoplastics. According to news originating from Cambridge, [...]

Subjects :: University of Cambridge -- Reports
Maintenance and repair
Research
Reports
Bexarotene -- Research
Physical fitness -- Research -- Reports
Multiple sclerosis -- Research

Tools